SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Elizabeth Barrett Browning — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientElizabeth Barrett Browning
Date of birth1806-03-06
IdentifiersMRN HR-NI026-SYN-TD; SSN (made up) 000-26-4157
Document date1845-03-23
AuthorClementine Haverford-Asante, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

One-week review, seen the same morning by pulmonology with CT of the chest and spirometry. [S]

History of Present Illness

Ms. Barrett Browning returns one week after her first visit and was seen this morning by Dr. Ellesmere-Park of pulmonology, who reviewed her CT and spirometry. Her three sputum samples were negative for acid-fast bacilli on smear and by nucleic acid amplification, her interferon-gamma release assay and HIV test were negative, and the routine culture grew Haemophilus influenzae. She has worn a mask with visitors and is relieved to hear that tuberculosis is very unlikely. Her cough and sputum are unchanged, about four tablespoons a day, and she saw one thin streak of blood three days ago. She takes morphine solution 5 mL twice daily as before and has used no extra. She has booked her first grief session for this week. She started vitamin D. [S]

ElementDetail
Results since last visitThree smears and NAAT negative; IGRA negative; HIV negative; sputum culture Haemophilus influenzae, beta-lactamase negative
SymptomsUnchanged cough with four tablespoons of sputum a day; one streak of blood three days ago
Testing todayCT of the chest with contrast; spirometry before and after bronchodilator; immunoglobulins, total IgE and Aspergillus IgE

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; no fever or night sweats
RespiratoryPositiveDaily productive cough; one streak of blood; breathless on one flight of stairs
CardiovascularPositivePalpitations at night now and then; no chest pain
PsychiatricPositiveMood heavy; no thoughts of self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Morphine sulfate 2 mg/mL oral solution, 5 mL (10 mg) by mouth twice daily, morning and bedtime (20 mg a day; long-standing prescription, continued)5 mL (10 mg) twice daily, morning and bedtimeOral route1838-03-01 to 1845-04-19completedS
Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeat in 2 to 3 minutes in the other nostril if no response; call 911As needed for suspected overdose; keep two devices at homeNasal route1845-03-16activeS
Cholecalciferol (vitamin D3) 1000 unit (25 mcg) oral tablet, two tablets (1819 units) by mouth dailyTwo tablets dailyOral route1845-03-16activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1845-03-23Body height157cmS
1845-03-23Body weight41.6kgS
1845-03-23Body mass index (BMI) [Ratio]16.9kg/m2S
1845-03-23Systolic blood pressure100mm[Hg]S
1845-03-23Diastolic blood pressure64mm[Hg]S
1845-03-23Heart rate92/minS
1845-03-23Respiratory rate18/minS
1845-03-23Body temperature36.8CelS
1845-03-23Oxygen saturation in Arterial blood by Pulse oximetry96%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1845-03-23FEV1 --post bronchodilation2.02LLower limit of normal for her age, sex and heightLowS
1845-03-23FEV1 measured/predicted74%>=80%LowS
1845-03-23Forced vital capacity [Volume] Respiratory system --post bronchodilation2.93LLower limit of normal for her age, sex and heightNormalS
1845-03-23FEV1/FVC --post bronchodilation0.69{ratio}Lower limit of normal for her age about 0.72LowS
1845-03-23IgG [Mass/volume] in Serum or Plasma1180mg/dL700-1600 mg/dLNormalS
1845-03-23IgA [Mass/volume] in Serum or Plasma236mg/dL70-400 mg/dLNormalS
1845-03-23IgM [Mass/volume] in Serum or Plasma142mg/dL40-230 mg/dLNormalS
1845-03-23IgE [Units/volume] in Serum or Plasma38[IU]/mL<=100 [IU]/mLNormalS
1845-03-23Aspergillus fumigatus IgE Ab [Units/volume] in Serum0.08k[IU]/LBelow 0.35 kU/L: negativeNormalS

Physical Exam

Vital signs recorded on 1845-03-23; see the Vital Signs section. [S]

SystemFinding
GeneralThin, alert; weight 41.6 kg; oxygen saturation 96% on room air
RespiratoryCoarse crackles at the left base and left mid-zone that shift with coughing; no wheeze; no clubbing
NeurologicalNot drowsy; pupils normal size
PsychiatricTearful once; engaged; no suicidal ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic cough with daily yellow sputum, occasional streaks of blood, and breathlessness on stairs, worse in winter, for several years after an illness with blood in the sputum about eight years ago; tuberculosis, nontuberculous mycobacteria and bronchiectasis to be distinguishedresolvedconfirmed R05.3S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the consultation; it echoes her documented chest illness (D).
Non-cystic fibrosis bronchiectasis of the left lower lobe and lingula with chronic Haemophilus influenzae infection and mild airflow obstruction (Bronchiectasis Severity Index 3, mild); tuberculosis and nontuberculous mycobacterial disease excluded; synthetic modern diagnosis chosen for a historical chest illness whose cause is disputedactiveconfirmed J47.9S — Synthetic modern diagnosis; the nature of her historical chest illness remains undetermined (R, disputed).
Long-term prescribed opioid therapy (oral morphine 20 mg a day for many years, for cough, sleeplessness and palpitations), with expected physiological dependence; no opioid use disorder on DSM-5-TR assessmentactiveconfirmed Z79.891S — Synthetic modern problem anchored to her documented prescribed opium (D); tolerance and withdrawal on prescribed opioids do not count toward opioid use disorder.
Prolonged grief disorder after the drowning of her closest brother five years ago, with yearning, self-blame, avoidance of reminders of the sea, and depressive symptoms (PHQ-9 12); no suicidal ideationactiveconfirmed F43.81S — Synthetic modern diagnosis anchored to her documented bereavement (D); not a claim about her real mental health.
Vitamin D deficiency (25-hydroxyvitamin D 15 ng/mL) in a woman who rarely goes outdoorsactiveconfirmed E55.9S — Synthetic finding at intake; repleted by twelve weeks.
Underweight (BMI 16.8) with a small appetiteactiveconfirmed R63.6S — Synthetic finding at intake.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryTuberculosis: acid-fast smear, nucleic acid amplification and culture on three sputum samples; interferon-gamma release assayOnce, at diagnosisCompleted todayThree sputum smears and NAAT negative; IGRA negative; HIV negative: tuberculosis very unlikely; masking stopped
LaboratoryMycobacterial culture including nontuberculous mycobacteriaAt diagnosis (final at six to eight weeks), then yearly and with unexplained declineOrderedCultures from the three samples in progress
ImagingCT of the chestOnce, to confirm the diagnosisCompleted todayCylindrical bronchiectasis of the left lower lobe and lingula; no cavity, nodule, mass or sequestration
LaboratoryCause of bronchiectasis: blood count, IgG, IgA and IgM, total IgE and Aspergillus-specific IgEOnce, at diagnosis; cystic fibrosis, ciliary and connective tissue tests only if the history suggests themCompleted todayBlood count normal at the first visit; IgG 1180, IgA 236, IgM 142 mg/dL; total IgE 38 IU/mL; Aspergillus IgE 0.08 kU/L: no immune deficiency or allergic aspergillosis; no features suggesting cystic fibrosis, a ciliary disorder or connective tissue disease
LaboratorySputum bacterial cultureAt each review and at every exacerbation, before antibioticsCompleted todayFirst-visit culture: Haemophilus influenzae, beta-lactamase negative; no Pseudomonas
ImagingSpirometry and Bronchiectasis Severity IndexAt diagnosis, then yearlyCompleted todayFEV1 2.02 L (74% predicted), FVC 2.93 L, FEV1/FVC 0.69 after bronchodilator; Bronchiectasis Severity Index 3, mild
Self-managementAirway clearance technique and exerciseEvery visitOrderedPhysiotherapy teaching session booked this week
Self-managementExacerbations: number in the past year, written plan, and rescue antibioticEvery visitCompleted todayAbout two winter chest infections a year by her account; written plan and rescue antibiotic given; long-term macrolide not indicated
Self-managementHemoptysis: amount, and when to seek emergency careEvery visitCompleted todayOne streak three days ago; emergency rules repeated
Self-managementInfluenza and pneumococcal vaccinesInfluenza yearly; pneumococcal onceDuePneumococcal vaccine at the next preventive visit; influenza in the autumn
Medication safetyOpioid benefits and harms: function, sleep, cough, sedation, breathing, constipation, and her goalsEvery visit, and at least every three monthsCompleted todayNo sedation; cough suppression discussed; no change
Medication safetyNaloxone at home, and no benzodiazepines or other sedativesEvery visitCompleted todayTwo naloxone devices at home; no sedatives
SurveyPHQ-9At least monthly during active treatment (CMID)Up to date12 one week ago; next at four weeks
ExaminationSuicide risk review and safety planEvery visitCompleted todayNo suicidal ideation; locked box in use
ReferralPulmonology reviewAt diagnosis, then as advisedCompleted todaySeen by Dr. Ellesmere-Park this morning

Goal progress:

Guideline basis: British Thoracic Society Guideline for Bronchiectasis in Adults (2019); European Respiratory Society guidelines for the management of adult bronchiectasis (2017); Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017); Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline (2020); CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression and osteoporosis monographs (2026)

Follow-up: Four-week review with the mycobacterial culture progress, sputum culture, DXA, PHQ-9 and the opioid plan. Emergency care for more than a few teaspoons of blood. Next scheduled visit 1845-04-20: four-week review: mycobacterial cultures, airway clearance, bone density, grief therapy, and her choice about the opioid dose. [S]